新天藥業(002873.SZ):藥品生產許可證變更
格隆匯3月19日丨新天藥業(002873.SZ)公佈,公司因生產經營需要申請變更《藥品生產許可證》,增加受託生產資質及分類碼變更,該事項已獲批準並於近日取得了貴州省藥品監督管理局換髮的《藥品生產許可證》。
公司本次《藥品生產許可證》變更的內容主要是增加了“受託生產”資質。委託方是貴州黔藥集團製藥有限公司(原名:貴州藥小子製藥有限公司),註冊地址是貴州省貴陽市雲巖區大營路街道大營坡中建華府(貴陽市大營坡片區棚戶區改造項目)B地塊B6棟33層11號,受託產品爲鹽酸班布特羅顆粒(批準文號:國藥準字H20050636,規格:2g:10mg),生產車間爲固體制劑車間一,生產線爲顆粒劑生產線,有效期至2025年10月27日,分類碼變更爲AhzyCh。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.